
Earl Blumenauer Periodic Transaction Report
Filed Mar 9, 2023 · House Clerk · 1 transaction
U.S. Representative · D · OR-03 · All trades by Earl Blumenauer
On March 9, 2023, Rep. Earl Blumenauer (D-OR-03) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 purchase) dated Feb 15, 2023.
The filing covers 1 ticker, including $NWN.
Reported amount ranges sum to $1K–$15K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 22 days.
1 transaction was reported under a spouse, dependent child, or joint account rather than the member directly.
Source document: House Clerk filing 20022546
Sample · the intelligence layer
Earl Blumenauer · Bought $NWN · Feb 15 · $1K–$15K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Earl Blumenauer
Get an email the moment Earl Blumenauer files the next one. Free, no card, no spam.
Tickers in this filing
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| Feb 15, 2023 | NWNNWNNorthwest Natural Holding Company | Northwest Natural Holding Company (NWN) | buy | Spouse | $1K–$15K | 22d |
The line under an asset name is the asset type the filer selected on the House form, shown with the House Clerk's label for that code. It is the filer's coding, not a classification by Coldpine.
Other recent filings by Earl Blumenauer
- PTR filed Dec 7, 20248 trades · CMCSA, BAC, KR, NWN
- PTR filed Nov 5, 20246 trades
- PTR filed Oct 8, 20246 trades · TGT, VTR
- PTR filed Sep 6, 20242 trades · NWN
- PTR filed Aug 6, 20245 trades · BAX, MDT, WBD
- PTR filed Jul 6, 20244 trades · CVS
← All congressional filings, newest firstFiled Mar 9, 2023March 2023 archive
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →